- Home
- MUSA vs ARWR Comparison
MUSA vs ARWR Comparison
Compare MUSA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MUSA | ARWR |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 9.6B |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | MUSA | ARWR |
|---|---|---|
| Price | $440.28 | $64.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $466.80 | $73.70 |
| AVG Volume (30 Days) | 269.7K | ★ 2.6M |
| Earning Date | 02-04-2026 | 02-09-2026 |
| Dividend Yield | ★ 0.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 23.64 | N/A |
| Revenue | ★ $17,008,099,999.00 | $829,448,000.00 |
| Revenue This Year | $11.17 | N/A |
| Revenue Next Year | $3.16 | N/A |
| P/E Ratio | $19.15 | ★ N/A |
| Revenue Growth | N/A | ★ 23258.15 |
| 52 Week Low | $345.23 | $9.57 |
| 52 Week High | $523.09 | $76.76 |
Technical Indicators
Market Signals| Indicator | MUSA | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 64.32 | 49.36 |
| Support Level | $412.53 | $64.72 |
| Resistance Level | $453.57 | $68.24 |
| Average True Range (ATR) | 12.07 | 3.63 |
| MACD | 2.14 | -1.03 |
| Stochastic Oscillator | 75.99 | 21.19 |
Price Performance
Historical ComparisonAbout MUSA Murphy USA Inc.
Murphy USA operates more than 1,700 fueling stations and convenience stores primarily across the Midwest and Southeastern United States. The firm owns about 75% of its locations, with most stores situated in high-traffic areas near Walmart supercenters. Murphy's stores typically range from 1,400-2,800 square feet, with most of its in-store sales derived from tobacco and nicotine products. The company acquired about 150 QuickChek stores in 2021, boosting its presence in grocery and foodservice. Murphy generates about two thirds of its profit from fuel retailing, with the remaining third coming from in-store sales.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.